Expanded Hemodialysis Therapy Market Size & Share, by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters); Modality (Short Daily, Conventional Long-Term, Nocturnal); Application (Priced Equipment, Service, Consumable, Drug); End-user (Hospital, Independent Dialysis, Home Dialysis) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3372
  • Published Date: Mar 21, 2023
  • Report Format: PDF, PPT

Companies Dominating the Expanded Hemodialysis Therapy Landscape

top-features-companies
    • B. Braun Melsungen AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Asahi Kasei Corporation
    • Baxter International, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Nikkiso Co., Ltd.
    • Nipro Corporation
    • NxStage Medical, Inc.
    • Cantel Medical Corp.
    • Satellite Healthcare, Inc.
    • MEDIVATORS, Inc. 

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • B. Braun Melsungen AG has finally acquired Intermedt Medizin & Technik GmbH which is allowing the company to complete its extensive portfolio as a systems provider for extracorporeal blood treatment (dialysis).

  • Asahi Kasei Corporation has obtained the approval for manufacturing and selling Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg in Japan for the treatment of the fungal infections of aspergillosis, mucormycosis, and cryptococcosis.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3372
  • Published Date: Mar 21, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major growth drivers for the market are the growing prevalence of diabetes and hypertension and increasing technological advancements to develop innovative therapies.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2035.

Complications and risks associated with dialysis coupled with the high cost associated with treatment are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Cantel Medical Corp., Satellite Healthcare, Inc., MEDIVATORS, Inc., and other key players.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, modality, end user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying